



{"id":2789,"date":"2018-09-10T17:04:02","date_gmt":"2018-09-10T15:04:02","guid":{"rendered":"http:\/\/www.medaid-h2020.eu\/?p=2789"},"modified":"2018-09-10T17:04:35","modified_gmt":"2018-09-10T15:04:35","slug":"health-forum-discussion-on-viral-encephalopathy-and-retinopathy","status":"publish","type":"post","link":"http:\/\/www.medaid-h2020.eu\/index.php\/2018\/09\/10\/health-forum-discussion-on-viral-encephalopathy-and-retinopathy\/","title":{"rendered":"Health forum discussion on Viral Encephalopathy and Retinopathy (VER)"},"content":{"rendered":"<p><strong>Dates:<\/strong> 17-28 September 2018<br \/>\n<strong>Forum coordinator:<\/strong>\u00a0Dr. Snje\u017eana Zrn\u010di\u0107, HVI. Zagreb, Croatia.<br \/>\n<strong>Discussion moderators:<\/strong><br \/>\nDr. Anna Toffan, IZSV, OIE Reference Laboratory for VER, Italy<br \/>\nDr. Alain le Breton, VETEAU, France<br \/>\nNiccol\u00f3 Vendramin, PhD student\/Veterinarian, DTU-Aqua, Denmark<\/p>\n<p>The discussion on\u00a0<em>Betanodavirus <\/em>is the second topic addressed by the MedAID Health Forum, which is conceived as a platform to gather field diagnosticians, laboratories, relevant authorities in charge of disease management in the Mediterranean mariculture and other stakeholders.<\/p>\n<p>Betanodavirus causes a disease known as <strong>Viral Encephalopathy and Retinopathy (VER)<\/strong>, also known as <strong>Viral Nervous Necrosis<\/strong> <strong>(VNN)<\/strong>. Since its first description during the early nineties, the disease is now endemic in the Mediterranean Sea and it is considered the most important viral disease affecting farmed and wild marine species. Betanodaviruses have an extended host range, including sea bass, groupers, flatfish and drums but the species that suffer more from this disease in the Mediterranean is undoubtedly the European sea bass (<em>Dicentrarchus labrax<\/em>).<!--more--><\/p>\n<p>Genetically different betanodaviruses (at present 4 parental genotypes and 2 reassortant genotypes have been described) show diverse phenotypes \u00a0and epidemiological features (antigenic properties, replication temperature, host tropism, virulence). This viral plasticity increases difficulties in diagnosis and controlling the disease. As an example, recently sea bream (<em>Sparus aurata<\/em>), a species previously considered resistant to the disease, showed to be susceptible during the larval stage to VER caused by RGNNV\/SJNNV genotype. The pathogenesis as well as the epidemiology of this virus in this species is largely unknown.<\/p>\n<p>VNN\/VER affected fish show typical nervous signs (corkscrew swimming, loss of buoyancy, blindness) with different levels of mortality depending on the virus, the affected fish species, the age, and other environmental factors. The virus is transmitted both horizontally and vertically. The extreme resistance of the betanodavirus in the marine water as well as the existence of \u201chealthy carrier\u201d among survivors play an important role for the spreading of the disease. As for the other viral disease, no treatment is available. The best way to fight the disease is the prevention by implementing effective biosecurity plan and vaccinating fish (if a vaccine is available). The limited availability of vaccines against VER is currently a big concern. Promising results are coming from genetic selection of VER resistant fish programs.<\/p>\n<p>To know more more about the\u00a0<a href=\"http:\/\/www.medaid-h2020.eu\/index.php\/2018\/09\/06\/viral-encephalopathy-and-retinopathy\/\" target=\"_blank\">Viral Encephalopathy and Retinopathy disease\u00a0you can read here in our blog the Mini-review written by Dr. Anna Toffan<\/a>.<br \/>\nTo know more about <a href=\"http:\/\/www.medaid-h2020.eu\/index.php\/2018\/09\/07\/prophylactic-measures-against-viral-encephalopathy-and-retinopathy-ver-and-vaccine-development\/\" target=\"_blank\">Prophylactic measures against Viral Encephalopathy and Retinopathy (VER) and vaccine development you can read here in our blog the Mini-review written by Sofie Bars\u00f8e<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>1. Objectives of the <em>Betanodavirus<\/em>\u00a0discussion<br \/>\n<\/strong>\u2022 To exchange the recent scientific data of a practical implication, with the health experts dealing with the problem caused by betanodaviruses in farmed fish<br \/>\n\u2022\u00a0To help farmer understanding diagnostic results and prognostic values of laboratory results<br \/>\n\u2022\u00a0To help farmers implementing their biosecurity level<br \/>\n\u2022\u00a0To share \u201ctips and tricks\u201d of farmers about how to deal with VER positive fish batch from one area to help farmers in other areas with the same problem<\/p>\n<p><strong>2. Process proposed to focus the discussion<br \/>\n<\/strong>The health farm experts are encouraged to share their valuable practical knowledge; the current prevention strategy should be profoundly evaluated and analyzed<\/p>\n<p><strong>3. The topics that should be discussed<br \/>\n<\/strong>\u2022<strong>\u00a0<\/strong>Epidemiology of VER in seabass and seabream<br \/>\n\u2022<strong>\u00a0<\/strong>Biosecurity rules<br \/>\n\u2022<strong>\u00a0<\/strong>Good aquaculture practices in prevention of VNN\/VER infection<br \/>\n\u2022<strong>\u00a0<\/strong>Disinfection methods<br \/>\n\u2022<strong>\u00a0<\/strong>Diagnostic methods choice and use<\/p>\n<p><a href=\"http:\/\/www.medaid-h2020.eu\/index.php\/community\/\" target=\"_blank\">Access to MedAID Health\u00a0Forum<br \/>\n<\/a><\/p>\n<p><a href=\"http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/04\/MedAID-Forum-user-guidelines.pdf\" target=\"_blank\"><img loading=\"lazy\" class=\"wp-image-2111 alignleft\" src=\"http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/04\/adobe-24943-274x300.png\" alt=\"adobe-24943\" width=\"37\" height=\"41\" srcset=\"http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/04\/adobe-24943-274x300.png 274w, http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/04\/adobe-24943-768x840.png 768w, http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/04\/adobe-24943-937x1024.png 937w, http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/04\/adobe-24943.png 1756w\" sizes=\"(max-width: 37px) 100vw, 37px\" \/><\/a><a href=\"http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/04\/MedAID-Forum-user-guidelines.pdf\" target=\"_blank\">Forum user&#8217;s guide<\/a><\/p>\n<p>&nbsp;<\/p>\n<div class=\"mceTemp\">\n<figure style=\"width: 150px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" class=\"size-thumbnail wp-image-2564\" src=\"http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/06\/DLLP3025-150x150.jpg\" alt=\"Dr. Snje\u017eana Zrn\u010di\u0107 Forum coordinator\" width=\"150\" height=\"150\" \/><figcaption class=\"wp-caption-text\">Dr. Snje\u017eana Zrn\u010di\u0107<br \/> Forum coordinator<\/figcaption><\/figure>\n<\/div>\n<figure style=\"width: 150px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" class=\"size-thumbnail wp-image-2776\" src=\"http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/09\/anna-toffan-1-150x150.jpg\" alt=\"Dr. Anna Toffan \" width=\"150\" height=\"150\" \/><figcaption class=\"wp-caption-text\">Dr. Anna Toffan<br \/> Discussion moderator<\/figcaption><\/figure>\n<figure style=\"width: 150px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" class=\"size-thumbnail wp-image-2797\" src=\"http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/09\/alain-150x150.jpg\" alt=\"Dr. Alain le Breton \" width=\"150\" height=\"150\" \/><figcaption class=\"wp-caption-text\">Dr. Alain Le Breton<br \/> Discussion moderator<\/figcaption><\/figure>\n<figure style=\"width: 150px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" class=\"size-thumbnail wp-image-2798\" src=\"http:\/\/www.medaid-h2020.eu\/wp-content\/uploads\/2018\/09\/Niccolo2-150x150.png\" alt=\"Niccol\u00f3 Vendramin Discussion moderator\" width=\"150\" height=\"150\" \/><figcaption class=\"wp-caption-text\">Niccol\u00f3 Vendramin<br \/> Discussion moderator<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Dates: 17-28 September 2018 Forum coordinator:\u00a0Dr. Snje\u017eana Zrn\u010di\u0107, HVI. Zagreb, Croatia. Discussion moderators: Dr. Anna Toffan, IZSV, OIE Reference Laboratory for VER, Italy Dr. Alain le Breton, VETEAU, France Niccol\u00f3 Vendramin, PhD student\/Veterinarian, DTU-Aqua, Denmark The discussion on\u00a0Betanodavirus is the second topic addressed by the MedAID Health Forum, which is conceived as a platform to&hellip;<\/p>\n","protected":false},"author":3,"featured_media":2792,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[87],"tags":[],"_links":{"self":[{"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/posts\/2789"}],"collection":[{"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/comments?post=2789"}],"version-history":[{"count":11,"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/posts\/2789\/revisions"}],"predecessor-version":[{"id":2803,"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/posts\/2789\/revisions\/2803"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/media\/2792"}],"wp:attachment":[{"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/media?parent=2789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/categories?post=2789"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.medaid-h2020.eu\/index.php\/wp-json\/wp\/v2\/tags?post=2789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}